EDAP TMS S.A. (EDAP)

Market Cap	90.90M
Revenue (ttm)	70.72M
Net Income (ttm)	-24.67M
Shares Out	37.10M
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,567
Open	2.430
Previous Close	2.390
Day's Range	2.394 - 2.669
52-Week Range	2.270 - 8.500
Beta	0.38
Analysts	Strong Buy
Price Target	14.00 (+471.43%)
Earnings Date	Nov 7, 2024

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urolog...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Jul 31, 1997
• Employees: 307
• Stock Exchange: NASDAQ
• Ticker Symbol: EDAP
• Website: https://www.edap-tms.com

Financial Performance

In 2023, EDAP TMS's revenue was 60.42 million, an increase of 9.64% compared to the previous year's 55.11 million. Losses were -21.18 million, 622.1% more than in 2022.

Financial numbers in EUR

Analyst Forecast

According to 2 analysts, the average rating for EDAP stock is "Strong Buy." The 12-month stock price forecast is $14.0, which is an increase of 471.43% from the latest price.

Price Target

$14.0

(471.43% upside)

Analyst Consensus: Strong Buy